What Is the First-Line Treatment of Tetanus?
Tetanus is a life-threatening neuromuscular illness caused by toxin-producing bacteria and requires prompt, structured clinical intervention. Management addresses both the toxin and its effects on muscle control, the autonomic nervous system, and airway patency.
Clinical Approach
First-line management of tetanus is multi-pronged. It addresses circulating toxin through immune globulin therapy, controls muscle spasms and autonomic instability through pharmacological support, and protects the airway in proportion to disease severity. Wound care — including debridement and appropriate antibiotic therapy — is also a core component.
Treatment Teaser
The structured regimen involves administration of immune globulin, sedation and muscle relaxant agents, and measures to secure and protect the airway. Wound management, including removal of necrotic tissue and antibiotic therapy, is part of the full protocol.
The complete regimen — including agent selection, dosing, sequencing, and airway decision criteria — is in the full protocol below.
References
- Medical experts recommend a single, 500 international unit (IU) dose of TIG for tetanus treatment.
- Administer TIG preparations intramuscularly.
- If TIG isn't available, healthcare providers can use immune globulin intravenous (IGIV) (dose 200 to 400 milligrams per kilogram).
- Healthcare providers should use sedation and muscle relaxant drugs as indicated to control muscle spasms.
- Patients may require agents to control autonomic nervous system instability.
- Depending on disease severity, endotracheal intubation or tracheostomy and mechanically assisted respiration may be lifesaving.
- Clean all wounds.
- Remove or debride necrotic tissue.
- Remove any foreign material.
- Appropriate antibiotic therapy is recommended to reduce the number of tetanus bacteria.
View source ↗